» Articles » PMID: 31963423

Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide As Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria

Abstract

A series of 2-thio- and 2-seleno-acetamides bearing the benzenesulfonamide moiety were evaluated as Carbonic Anhydrase (CA, EC 4.2.1.1) inhibitors against different pathogenic bacteria such as the (VchCA-α and VchCA-β), (BpsCA-β and BpsCA-γ), (Rv3723-β) and the (StCA2-β). The molecules represent interesting leads worth developing as innovative antibacterial agents since they possess new mechanism of action and isoform selectivity preferentially against the bacterial expressed CAs. The identification of potent and selective inhibitors of bacterial CAs may lead to tools also useful for deciphering the physiological role(s) of such proteins.

Citing Articles

Synthesis, Biological and In Silico Studies of Griseofulvin and Usnic Acid Sulfonamide Derivatives as Fungal, Bacterial and Human Carbonic Anhydrase Inhibitors.

Angeli A, Petrou A, Kartsev V, Lichitsky B, Komogortsev A, Capasso C Int J Mol Sci. 2023; 24(3).

PMID: 36769114 PMC: 9917406. DOI: 10.3390/ijms24032802.


Enhancing the Activity of Carboxymethyl Cellulase Enzyme Using Highly Stable Selenium Nanoparticles Biosynthesized by Y4.

Wang Y, Yu Y, Duan Y, Wang Q, Cong X, He Y Molecules. 2022; 27(14).

PMID: 35889450 PMC: 9324468. DOI: 10.3390/molecules27144585.


Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies.

Angeli A, Kartsev V, Petrou A, Lichitsky B, Komogortsev A, Pinteala M Pharmaceuticals (Basel). 2022; 15(3).

PMID: 35337114 PMC: 8955975. DOI: 10.3390/ph15030316.


The Role of Selenium in Pathologies: An Updated Review.

Barchielli G, Capperucci A, Tanini D Antioxidants (Basel). 2022; 11(2).

PMID: 35204134 PMC: 8868242. DOI: 10.3390/antiox11020251.


Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors.

Havrankova E, Garaj V, Mascaretti S, Angeli A, Soldanova Z, Kemka M Int J Mol Sci. 2022; 23(1).

PMID: 35008657 PMC: 8745223. DOI: 10.3390/ijms23010231.


References
1.
Capasso C, Supuran C . Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat. 2013; 23(6):693-704. DOI: 10.1517/13543776.2013.778245. View

2.
Supuran C . Structure and function of carbonic anhydrases. Biochem J. 2016; 473(14):2023-32. DOI: 10.1042/BCJ20160115. View

3.
Angeli A, Carta F, Bartolucci G, Supuran C . Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors. Bioorg Med Chem. 2017; 25(13):3567-3573. DOI: 10.1016/j.bmc.2017.05.014. View

4.
Alafeefy A, Ceruso M, Al-Tamimi A, Del Prete S, Capasso C, Supuran C . Quinazoline-sulfonamides with potent inhibitory activity against the α-carbonic anhydrase from Vibrio cholerae. Bioorg Med Chem. 2014; 22(19):5133-40. DOI: 10.1016/j.bmc.2014.08.015. View

5.
Angeli A, Tanini D, Nocentini A, Capperucci A, Ferraroni M, Gratteri P . Selenols: a new class of carbonic anhydrase inhibitors. Chem Commun (Camb). 2018; 55(5):648-651. DOI: 10.1039/c8cc08562e. View